SB
ICPT
Samsara BioCapital’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-640,688
| Closed | -$11.9M | – | 44 |
|
|
2023
Q3 | $11.9M | Hold |
640,688
| – | – | 3.64% | 7 |
|
|
2023
Q2 | $7.09M | Hold |
640,688
| – | – | 1.24% | 16 |
|
|
2023
Q1 | $8.6M | Hold |
640,688
| – | – | 1.78% | 13 |
|
|
2022
Q4 | $7.93M | Hold |
640,688
| – | – | 1.71% | 16 |
|
|
2022
Q3 | $8.94M | Hold |
640,688
| – | – | 2.08% | 12 |
|
|
2022
Q2 | $8.85M | Hold |
640,688
| – | – | 2.36% | 10 |
|
|
2022
Q1 | $10.4M | Hold |
640,688
| – | – | 2.62% | 11 |
|
|
2021
Q4 | $10.4M | Hold |
640,688
| – | – | 2.02% | 12 |
|
|
2021
Q3 | $9.51M | Hold |
640,688
| – | – | 1.49% | 14 |
|
|
2021
Q2 | $12.8M | Hold |
640,688
| – | – | 1.58% | 14 |
|
|
2021
Q1 | $14.8M | Buy |
640,688
+237,000
| +59% | +$5.47M | 2.73% | 9 |
|
|
2020
Q4 | $9.97K | Hold |
403,688
| – | – | 1% | 11 |
|
|
2020
Q3 | $16.7M | Hold |
403,688
| – | – | 4.67% | 7 |
|
|
2020
Q2 | $19.3M | Hold |
403,688
| – | – | 6.22% | 5 |
|
|
2020
Q1 | $25.4M | Hold |
403,688
| – | – | 14.63% | 1 |
|
|
2019
Q4 | $50M | Hold |
403,688
| – | – | 23.97% | 1 |
|
|
2019
Q3 | $26.8M | Buy |
403,688
+72,991
| +22% | +$4.84M | 18.23% | 1 |
|
|
2019
Q2 | $26.3M | Buy |
330,697
+119,760
| +57% | +$9.53M | 17.38% | 1 |
|
|
2019
Q1 | $23.6M | Sell |
210,937
-23,438
| -10% | -$2.62M | 18.54% | 1 |
|
|
2018
Q4 | $23.6M | Buy |
+234,375
| New | +$23.6M | 22.67% | 2 |
|